Shaanxi Meibang Pharmaceutical Group Co., Ltd. / Fundamentals

    Income statement

    Net revenue
    €103.74M
    Cost of goods sold
    €74.09M
    Gross profit
    €29.66M
    SG&A expenses
    €13.40M
    R&D expenses
    €9.32M
    EBITDA
    €3.54M
    D&A
    €665.40K
    EBIT
    €642.08K
    Interest expenses
    €19.77K
    EBT
    €2.34M
    Tax expenses
    -€358.49K
    Net income
    €2.69M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €15.58M
    Changes in working capital
    -€14.83M
    Operating cash flow
    €14.77M
    Capex
    €19.59M
    Other investing cash flow
    €271.20K
    Net investing cash flow
    -€27.14M
    Total cash dividends paid
    -€3.40M
    Issuance of common stock
    €0.00
    Debt repayment
    €8.67M
    Other financing cash flow
    -€4.37M
    Net financing cash flow
    €901.31K
    Foreign exchange effects
    €0.02
    Net change in cash
    -€4.46M
    Cash at end of period
    €19.50M
    Free cash flow
    €34.36M

    Balance sheet

    Cash and cash equivalents
    €28.84M
    Cash and short-term investments
    €59.56M
    Total receivables
    €20.77M
    Inventory
    €27.20M
    Other current assets
    €12.78M
    Total current assets
    €120.31M
    Property, plant & equipment
    €76.26M
    Goodwill
    €0.00
    Intangible assets
    €14.16M
    Long-term investments
    €0.24
    Other non-current assets
    €8.24M
    Total non-current assets
    €100.42M
    Total assets
    €220.73M
    Accounts payable
    €42.18M
    Short-term debt
    €0.00
    Other current liabilities
    €17.00M
    Total current liabilities
    €59.35M
    Long-term debt
    €8.67M
    Deferred tax liabilities
    €547.85K
    Other non-current liabilities
    €12.71M
    Total non-current liabilities
    €22.31M
    Total liabilities
    €81.66M
    Common stock
    €16.28M
    Retained earnings
    €64.02M
    Other equity
    €0.00
    Total equity
    €139.07M
    Total liabilities and shareholders' equity
    €220.73M

    Company information

    Market capitalization
    €318.83M
    Employees
    939
    Enterprise Value
    €2.85B

    Company ratios

    Gross margin
    28.6% Better than peer group: 22.2%
    EBITDA margin
    3.4% Worse than peer group: 11.9%
    EBIT margin
    0.6% Worse than peer group: 8.1%
    EBT margin
    2.3% Worse than peer group: 8.2%
    Net margin
    2.6% Even with peer group: 7.0%
    ROE
    1.9% Worse than peer group: 8.0%
    ROA
    1.2% Even with peer group: 5.5%
    Asset turnover
    47.0% Much worse than peer group: 78.2%
    FCF margin
    -4.6% Even with peer group: -7.5%
    FCF yield
    -1.5%
    Efficiency ratio
    96.6%
    Net sales per employee
    €110.48K
    Net income per employee
    €2.87K

    Notifications